300318.SZ
Beijing Bohui Innovation Biotechnology Group Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 4.66
+0.65%Year over year
Reported trailing growth
- Revenue
- +2.7%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- -18.3%
- Operating cash flow
- -43.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +1.2%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -28.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026